Drug target expression in pulmonary langerhans´cell histiocytosis

J. Loeffler-Ragg, E. Stacher, J. Guenther, P. Stoitzner, K. Cima, S. Desole, H. H. Popper, C. M. Kaehler (Austria)

Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Loeffler-Ragg, E. Stacher, J. Guenther, P. Stoitzner, K. Cima, S. Desole, H. H. Popper, C. M. Kaehler (Austria). Drug target expression in pulmonary langerhans´cell histiocytosis. Eur Respir J 2010; 36: Suppl. 54, 2345

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Expression of potential therapeutic targets in pulmonary Langerhans´ cell histiocytosis
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009


Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


A case with pulmonary histiocytosis X and lung cancer
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Pulmonary Langerhans' cell histiocytosis
Source: Respipedia Article
Year: 2016

Chemotherapy in patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018



Cladribine improves lung cysts and pulmonary function in a child with histiocytosis
Source: Eur Respir J 2015; 45: 831-833
Year: 2015


Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Paediatric pulmonary Langerhans cell histiocytosis
Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020
Year: 2020



Pulmonary histiocytosis triggered by marijuana- and nicotine-abuse
Source: Eur Respir J 2002; 20: Suppl. 38, 338s
Year: 2002

Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis
Source: Eur Respir Mon 2012; 57: 161-165
Year: 2012


Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis
Source: ERJ Open Res, 4 (1) 00089-2017; 10.1183/23120541.00089-2017
Year: 2018



Pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008



Pulmonary Langerhans‘ cell histiocytosis
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006

Pulmonary Langerhans‘ cell histiocytosis (PLCH): A new UK register
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012


Adult pulmonary Langerhans‘ cell histiocytosis and lung cancer
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009

Pulmonary Langerhans' cell histiocytosis
Source: Eur Respir Mon; 2009: 46: 155–175
Year: 2009

Pathological findings in histiocytosis X with pulmonary hypertension
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012

Genetic landscape of pulmonary langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018

Special features in progress of cases with pulmonary histiocytosis X
Source: Eur Respir J 2002; 20: Suppl. 38, 59s
Year: 2002